Penumbra Inc (PEN)
About Penumbra Inc
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $1.4B
- Net income
- $177.7M
- Total assets
- $1.8B
- Market cap
- $12.5B
- Gross margin
- 67.1%
- Operating margin
- 13.5%
- Net margin
- 12.7%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $1.4B
- Cost of revenue
- $461.2M
- Gross profit
- $942.4M
- Operating expenses
- $753.2M
- Operating income
- $189.2M
- Income tax
- $27.4M
- Net income
- $177.7M
- EPS (basic)
- $4.57
- EPS (diluted)
- $4.52
Balance sheet
- Total assets
- $1.8B
- Current assets
- $1.2B
- Total liabilities
- $398.9M
- Current liabilities
- $183.1M
- Shareholders’ equity
- $1.4B
Cash flow
- Operating cash flow
- $238.7M
- Investing cash flow
- -$404.6M
- Financing cash flow
- $26.5M
- Net cash flow
- -$137.5M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $12.5B
- P/E ratio
- 71.0
- EPS (diluted)
- $4.52
- Shares outstanding
- 39.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 18, 2015
Penumbra Inc (PEN) Stock Price
- Profitable — net income of $177.7M in FY2025.
- Revenue grew 88% from FY2021 to FY2025.
- Gross margin of 67.1%, net margin 12.7%.
- Trading 11% below its 52-week high.
- Valued at a price-to-earnings (P/E) ratio of 71.0.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review Penumbra Inc.
Write a review
News about Penumbra Inc
News & sentiment via Polygon.io
Penumbra Inc: frequently asked questions
Is Penumbra Inc an American company?
Yes — Penumbra Inc is an American company headquartered in Alameda, California. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.
Where is Penumbra Inc headquartered?
Penumbra Inc is headquartered in Alameda, California, United States.
Is Penumbra Inc publicly traded?
Yes — Penumbra Inc is a publicly traded company. Its stock trades under the ticker symbol PEN on the NYSE.
What does Penumbra Inc do?
Penumbra Inc is an American Medical Devices company in the Health & Beauty sector.
